Emerging Evidence

Safety Concerns

Report 40: Data Do Not Support Safety of mRNA COVID Vaccination for Pregnant Women - DailyClout

Urgent Open Letter from Doctors and Scientists to the European Medicines Agency regarding COVID-19 Vaccine Safety Concerns – Doctors for COVID Ethics

Official Letter to the Royal Commission of Inquiry: mRNA Vaccine Safety Concerns

mRNA vaccine toxicity

Increased rates of miscarriage

The results provide evidence for a substantially higher-than-expected number of eventual fetal losses associated with COVID-19 vaccination during gestational weeks 8-13.

Observed-to-Expected Fetal Losses Following mRNA COVID-19 Vaccination in Early Pregnancy | medRxiv

Evidence of transplacental and breastmilk distribution

(PDF) Inadvertent Exposure to Pharmacologically Designed Lipid Nanoparticles Via Bodily Fluids: Biologic Plausibility and Potential Consequences

Transplacental transmission of the COVID-19 vaccine messenger RNA: evidence from placental, maternal, and cord blood analyses postvaccination

Reduced HSPCs (immune function) in umbilical blood

These results indicate that SARS-CoV-2 infection and COVID-19 vaccination impair the functionalities and survivability of HSPCs in the UCB, which would make unprecedented concerns on the future of HSPC-based therapies.

Skewed fate and hematopoiesis of CD34+ HSPCs in umbilical cord blood amid the COVID-19 pandemic - PubMed

DNA contamination

In this study we present evidence that COVID-19 mRNA vaccine BNT162b2 is able to enter the human liver cell line Huh7 in vitro. BNT162b2 mRNA is reverse transcribed intracellularly into DNA as fast as 6 h after BNT162b2 exposure. A possible mechanism for reverse transcription is through endogenous reverse transcriptase LINE-1, and the nucleus protein distribution of LINE-1 is elevated by BNT162b2. Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line

(PDF) Speicher DJ et al, DNA fragments detected in COVID-19 vaccines in Canada. DNA fragments detected in monovalent and bivalent

New evidence of DNA contamination in mRNA vaccines – too big to ignore - Science, Public Health Policy and the Law

"The mRNA-LNP Vaccines - The Good, The Bad and The Ugly?" by Botond Z. Igyártó and Zhen Qin

OIA MEDSAFE H2023032746_response.pdf

Potential Mechanisms for Human Genome Integration of Genetic Code from SARS-CoV-2 mRNA Vaccination: Implications for Disease | Abstract

This study emphasizes the importance of methodological considerations when quantifying residual plasmid DNA in modRNA products, considering increased LNP transfection efficiency, and cumulative dosing presents significant and unquantified risks to human health.